129 related articles for article (PubMed ID: 21983456)
1. [Outcomes of using autologous peripheral-blood stem cells in patients with chronic lower arterial insufficiency].
Maksimov AV; Kiiasov AP; Plotnikov MV; Maianskaia SD; Shamsutdinova II; Gazizov IM; Mavlikeev MO
Angiol Sosud Khir; 2011; 17(2):11-5. PubMed ID: 21983456
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
[TBL] [Abstract][Full Text] [Related]
5. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
[TBL] [Abstract][Full Text] [Related]
7. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
8. [Safety and efficacy of intracoronary transplantation of G-CSF mobilized autologous peripheral blood stem cells in patients with acute myocardial infarction].
Li ZQ; Zhang M; Jin YZ; Zhang WW; Liu Y; Yuan L; Cui LJ; Liu XZ; Yu X; Hu TS
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):99-102. PubMed ID: 16626571
[TBL] [Abstract][Full Text] [Related]
9. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
[TBL] [Abstract][Full Text] [Related]
10. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
[TBL] [Abstract][Full Text] [Related]
11. [Autologous peripheral blood stem cell transplantation for the treatment of lower extremity arterial occlusive disease].
Wang L; Dong SM; Jiang QZ; Nan JL; Liu YG; Li SR; Feng XM
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):345-8. PubMed ID: 16776930
[TBL] [Abstract][Full Text] [Related]
12. Calf muscle stimulation with the Veinoplus device results in a significant increase in lower limb inflow without generating limb ischemia or pain in patients with peripheral artery disease.
Abraham P; Mateus V; Bieuzen F; Ouedraogo N; Cisse F; Leftheriotis G
J Vasc Surg; 2013 Mar; 57(3):714-9. PubMed ID: 23312939
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
Gu Y; Zhang J; Qi L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia.
Mohammadzadeh L; Samedanifard SH; Keshavarzi A; Alimoghaddam K; Larijani B; Ghavamzadeh A; Ahmadi AS; Shojaeifard A; Ostadali MR; Sharifi AM; Amini MR; Mahmoudian A; Fakhraei H; Aalaa M; Mohajeri-Tehrani MR
Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):48-53. PubMed ID: 23329572
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of using VEGF165 gene in comprehensive treatment of patients with stage 2A-3 lower limb chronic ischaemia].
Deev RV; Bozo IIa; Mzhavanadze ND; Nersesian EG; Chukhralia OV; Shval'b PG; Cherviakov IuV; Staroverov IN; Kalinin RE; Voronov DA; Gavrilenko AV; Isaev AA
Angiol Sosud Khir; 2014; 20(2):38-48. PubMed ID: 24961325
[TBL] [Abstract][Full Text] [Related]
16. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S
Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
[TBL] [Abstract][Full Text] [Related]
17. Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment.
Lysak D; Koza V; Steinerova K; Jindra P; Vozobulova V; Schutzova M
Ann Hematol; 2005 Jul; 84(7):456-61. PubMed ID: 15770494
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia].
Gu Y; Zhang J; Qi L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jul; 21(7):675-8. PubMed ID: 17694651
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.
Spitzer G; Adkins D; Mathews M; Velasquez W; Bowers C; Dunphy F; Kronmueller N; Niemeyer R; McIntyre W; Petruska P
Bone Marrow Transplant; 1997 Dec; 20(11):921-30. PubMed ID: 9422470
[TBL] [Abstract][Full Text] [Related]
20. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
